Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 23, 2021
Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomesHaowei Linda Sun, Ming Yang, Man-Chiu Poon, et al.Research and Practice in Thrombosis and Haemostasis|October 20, 2021
The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia BHaowei Linda Sun, Ming Yang, Man-Chiu Poon, et al.The British Journal of Surgery|May 7, 2026
Clinical and molecular landscape of surgically resected early onset pancreatic cancerStephan B Dreyer, Adam Bryce, Fieke Froeling, et al.Haematologica|January 7, 2018
Desmopressin in moderate hemophilia A patients: a treatment worth consideringJanneke I Loomans, Marieke J H A Kruip, Manuel Carcao, et al.Thrombosis and Haemostasis|January 28, 2021
A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A SubjectsVictor S Blanchette, Laura Zunino, Viviane Grassmann, et al.Research and Practice in Thrombosis and Haemostasis|January 16, 2026
Comparative safety of drug therapies used in hemophilia A and B in Canada: a multi-center, retrospective studyOmotola O Olasupo, Emma Iserman, Arun Keepanasseril, et al.Journal of Thrombosis and Haemostasis : JTH|July 14, 2026
Evaluation of the determinants of FVIII/FIX levels, bleeding score, and health-related quality of life in the Canadian hemophilia carriers (CHiC) studyLaura L Swystun, Julie Grabell, Megan Hinds, et al.Journal of Thrombosis and Haemostasis : JTH|October 25, 2024
Pregnancy loss in individuals with von Willebrand disease and unspecified mucocutaneous bleeding disorders: a multicenter cohort studyLeslie Skeith, Paula James, Peter Kouides, et al.American Journal of Hematology|April 2, 2026
Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic StudyEmily Leung, Nicholas R Fragola, Elliott W Sharp, et al.Research and Practice in Thrombosis and Haemostasis|September 12, 2022
Desmopressin for bleeding in non-severe hemophilia A: Suboptimal use in a real-world settingAnne-Fleur Zwagemaker, Fabienne R Kloosterman, Michiel Coppens, et al.Pageof 4